<?xml version="1.0" encoding="UTF-8"?>
<p>Table 
 <xref rid="psb1843-tbl-0001" ref-type="table">1</xref> lists some of the drugs currently reported as under investigation specifically for treating COVID‐19; others that have shown potential for the treatment of SARS and MERS are also being evaluated on the basis that the viruses share structural similarities with SARS‐CoV‐2. These include novel agents in development and antivirals currently in use for other indications, and several studies have also evaluated potential treatments 
 <italic>in vitro</italic>.
 <xref rid="psb1843-bib-0031" ref-type="ref">
  <sup>31</sup>
 </xref>, 
 <xref rid="psb1843-bib-0032" ref-type="ref">
  <sup>32</sup>
 </xref>, 
 <xref rid="psb1843-bib-0033" ref-type="ref">
  <sup>33</sup>
 </xref> Treatments appear to have been introduced in China but are not well reported in English language scientific literature. China, as the country with the longest experience of managing COVID‐19, is likely to have valuable expertise to share with other states. To date (early May), no drug treatment has been proven to be effective.
</p>
